medroxyprogesterone has been researched along with Colonic Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biemond, I; D'Haens, G; de Jonge-Muller, ES; Ederveen, A; Groothuis, P; Hardwick, JC; Heijmans, J; Hommes, DW; Muncan, V; Roelofs, J; Rosekrans, SL; van den Brink, GR; van Lidth de Jeude, JF; Wielenga, MC | 1 |
Cornuz, J; Lamy, O; Wirthner, D | 1 |
Amato, G; Capuano, F; Carella, C; Figlia, A; Papaleo, C; Zito, GA | 1 |
Contieri, E; Zannini, G | 1 |
Brøns, J; Jensen, LK; Rasmussen, J | 1 |
1 review(s) available for medroxyprogesterone and Colonic Neoplasms
Article | Year |
---|---|
[Preventing of postmenopausal osteoporosis by hormone replacement therapy? Is the risk acceptable?].
Topics: Age Factors; Aged; Alzheimer Disease; Breast Neoplasms; Cardiovascular Diseases; Climacteric; Colonic Neoplasms; Endometrial Neoplasms; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hysterectomy; Medroxyprogesterone; Meta-Analysis as Topic; Middle Aged; Multivariate Analysis; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Placebos; Prognosis; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Risk; Risk Factors; Socioeconomic Factors; Time Factors | 2004 |
1 trial(s) available for medroxyprogesterone and Colonic Neoplasms
Article | Year |
---|---|
Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Leukopenia; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Random Allocation; Rectal Neoplasms; Thrombocytopenia; Time Factors | 1986 |
4 other study(ies) available for medroxyprogesterone and Colonic Neoplasms
Article | Year |
---|---|
Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer.
Topics: Animals; Azoxymethane; Carcinogenesis; Colitis; Colonic Neoplasms; Cytokines; Dextran Sulfate; Disease Models, Animal; Estradiol; Estrogens; Female; Hormone Replacement Therapy; Immunohistochemistry; Medroxyprogesterone; Mice; Ovariectomy | 2014 |
ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages.
Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Uterine Neoplasms | 1984 |
[Hormone receptors in colonic cancer].
Topics: Colonic Neoplasms; Female; Fluorouracil; Humans; Lomustine; Male; Medroxyprogesterone; Prognosis; Receptors, Cell Surface | 1982 |
Hormone treatment of stromal endometriosis.
Topics: Adult; Colonic Neoplasms; Endometriosis; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen; Vaginal Neoplasms | 1980 |